SignatureFD’s Sana Biotechnology SANA Stock Holding History

SignatureFD’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.1K	Hold	3,507	–	–	﹤0.01%	2506
2025 Q4	$14.3K	Hold	3,507	–	–	﹤0.01%	2261
2025 Q3	$12.4K	Hold	3,507	–	–	﹤0.01%	2328
2025 Q2	$9.57K	Buy	3,507 +58	+2%	+$120	﹤0.01%	2366
2025 Q1	$5.79K	Buy	3,449 +2,852	+478%	+$7.97K	﹤0.01%	2547
2024 Q4	$973	Sell	597 -112	-16%	-$334	﹤0.01%	3037
2024 Q3	$2.95K	Buy	709 +466	+192%	+$2.45K	﹤0.01%	2723
2024 Q2	$1.33K	Hold	243	–	–	﹤0.01%	2848
2024 Q1	$2.43K	Sell	243 -159	-40%	-$1.19K	﹤0.01%	2754
2023 Q4	$1.64K	Sell	402 -2,616	-87%	-$9.64K	﹤0.01%	2809
2023 Q3	$11.7K	Hold	3,018	–	–	﹤0.01%	2123
2023 Q2	$18K	Buy	3,018 +585	+24%	+$3.37K	﹤0.01%	1950
2023 Q1	$7.96K	Buy	2,433 +1,743	+253%	+$6.96K	﹤0.01%	2308
2022 Q4	$2.73K	Buy	+690	New	+$3.37K	﹤0.01%	2703

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marex Group London $15.8B AUM 31.44% 1-Year Est. Return

IHAM

Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

SignatureFD's SANA Position: Q1 2026 in Review

SignatureFD held its Sana Biotechnology (SANA) position steady in Q1 2026 at 3,507 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2506.

SignatureFD first reported a position in SANA in Q4 2022 and has held it in 14 quarters since. The position peaked at $18K in Q2 2023. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

SignatureFD held 3,507 shares of Sana Biotechnology worth $10.1K as of Q1 2026.
SignatureFD left its Sana Biotechnology share count unchanged in Q1 2026.
Sana Biotechnology made up ﹤0.01% of SignatureFD's portfolio in Q1 2026, its #2506 holding.
SignatureFD first reported a position in Sana Biotechnology in Q4 2022 and has held it in 14 quarters since.
SignatureFD's Sana Biotechnology position peaked at $18K in Q2 2023.
202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.